For example, Kawanaka et al. followed 489 patients with biopsy-proven NAFLD for 1–22.2 years [21] and found that patients with an albumin level < 3.5 g/dL, platelet counts < 150 × 109 /L, and type IV collagen 7S levels ≥ 5 ng/mL indicate a poor prognosis. Here, ALB is linked to metabolic dysfunction-associated steatotic liver disease.